Related Experiment Videos
Recurrence pattern and proposed surveillance protocol following post-chemotherapy retroperitoneal lymph node
Philippe E Spiess1, Gordon A Brown, Ping Liu
1Department of Urologic Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
The Journal of Urology
|December 13, 2006
Summary
Recurrence after nonseminomatous germ cell tumor treatment with retroperitoneal lymph node dissection most frequently occurs in the chest. Stage-specific surveillance guidelines are proposed to optimize follow-up for patients at high risk of disease progression.
Area of Science:
- Oncology
- Urology
- Surgical Oncology
Background:
- Nonseminomatous germ cell tumors (NSGCT) are a significant cause of cancer in young men.
- Post-chemotherapy retroperitoneal lymph node dissection (RPLND) is a critical component in the management of advanced NSGCT.
- Understanding recurrence patterns after RPLND is essential for optimizing patient surveillance.
Purpose of the Study:
- To evaluate the recurrence patterns in patients with NSGCT treated with post-chemotherapy RPLND.
- To determine the optimal surveillance strategy for these patients based on recurrence data.
Main Methods:
- Retrospective review of 198 patients with clinical stage IIA-III NSGCT who underwent post-chemotherapy RPLND between 1980 and 2003.
- Exclusion of patients with elevated preoperative tumor markers.
- Analysis of recurrence sites, timing, and association with clinical stage.
Main Results:
- Recurrence developed in 23% of patients (45/198), with 11% dying of disease.
- The most frequent recurrence site was the chest (49%), followed by the abdomen (22%).
- Recurrence rates were higher in advanced clinical stages (Stage III: 46.7%, Stage IIC: 40%).
Conclusions:
- The recurrence pattern after post-chemotherapy RPLND is stage-dependent.
- Stage-specific surveillance guidelines are proposed to improve the identification of patients at high risk for progression.
- These guidelines aim to tailor postoperative follow-up intensity based on individual patient risk stratification.